整合机器学习方法预测痴呆和阿尔茨海默病的风险
1The Rachel and Selim Benin School of Computer Science and Engineering, The Hebrew University of Jerusalem, Jerusalem, Israel.
GeroScience
|August 27, 2025
概括
机器学习模型有效地使用英国生物库数据预测痴呆风险, 整合健康,遗传和生活方式因素. 特别是在女性中,CatBoost表现强,突出了个性化干预的潜力.
科学领域:
- 神经科学
- 遗传学
- 计算生物学
背景情况:
- 痴呆症,包括阿尔茨海默病 (AD),是一个日益严重的全球健康问题,需要及早诊断和干预.
- 增加预期寿命需要先进的临床策略来管理认知衰退和独立性丧失.
研究的目的:
- 开发和评估用于预测阿尔茨海默病和血管痴呆风险的机器学习 (ML) 模型.
- 整合各种数据来源,包括健康记录,遗传信息和生活方式因素,以提高预测准确度.
主要方法:
- 使用英国生物库数据,包括2878例AD病例和72,366例对照病例.
- 开发并比较各种ML算法,其中CatBoost表现出优异的性能 (ROC-AUC=0.773).
- 将ICD-10代码 (诊断前5年),ApoE-ε4基因型和可修改的风险因素纳入预测模型.
主要成果:
- CatBoost模型的ROC-AUC为0.773,显示出显著的预测能力,特别是在女性中.
- 尽管病例数较少,但血管痴呆 (VaD) 风险模型的表现优于AD特定模型.
- ApoE-ε4是最重要的遗传预测因子;常见的变体显示出有限的效用. 关键的非遗传预测因素包括并发症,教育,体力活动和饮食.
结论:
- 整合多种数据源与ML可以提高痴呆风险预测.
- 对于早期个性化的痴呆症干预, 性别特定的建模和对可修改因素的关注至关重要.
- 机器学习为积极的痴呆症管理和个性化医疗保健策略提供了一个有前途的途径.
更多相关视频
09:47Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.2K
06:46Automated, Long-term Behavioral Assay for Cognitive Functions in Multiple Genetic Models of Alzheimer's Disease, Using IntelliCage
Published on: August 4, 2018
12.3K
相关概念视频
01:26Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
01:22Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260
01:30Dementia
165
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
165